This is my 48th article about Gardasil, following by just a few hours, my 47th. After my 50th, I get a watch made from the gold hidden in the subterranean vaults of the Big Pharma overlords who generates bundles of cash from vaccines. Oh, I keep forgetting–that’s not true.
Despite the overwhelming evidence that the HPV quadrivalent vaccine, also known as Gardasil (or Silgard in Europe) can prevent human papillomavirus (HPV) infection, the most common sexually transmitted infection (STI) in the USA, which is linked to cervical, anal, vulvar, vaginal, oropharyngeal and penile cancer, HPV vaccine uptake is not as high as other vaccines. A recent report from the CDC, published in Morbidity and Mortality Weekly Report, states that only 57% of girls and 35% of boys, aged 13-17 years, have received at least one of the three recommended doses of the HPV vaccine. This is far short of the goal of Healthy People 2020, the CDC’s initiative to set clear objectives and strategies to improve the health of Americans, that 80% of American teens have received all three doses of the HPV vaccine by 2020.
Currently in the United States, the Advisory Committee on Immunization Practices (ACIP) recommends that preteen girls and boys aged 11 or 12 are vaccinated against HPV. The immunization is also recommended for teenage girls and young women up to the age of 26 who did not receive it when they were younger, and teenage boys and young men up to the age of 21.Read More »OK, why aren’t kids getting vaccinated with Gardasil?